Abstract
[Extract] Oxytocin, a nine amino acid neuropeptide, first discovered by Sir Heury Dale in 1906, is a potent modulator of a variety of brain functions including emotions, mood, social and sexual behaviour and learning and memory (Gimpl & Fahrenholz 2001). It has been reported that oxytocin also profoundly influences the neurobiological processes underlying drug addiction (Sarnyai & Kovacs 1994). In particular, we and others have demonstrated the inhibitory effects of oxytocin on acute behavioural effects, sensitisation and tolerance as well as on self-administration of the psychostimulant cocaine (Sarnyai & Kovacs 1994). These results raise the possibility of the development of oxytocin-based medication for psychostimulant addiction. However, despite these well-documented effects, the mechanism of action of this neuropeptide on the addictive processes is still unknown. Two papers in this issue of Addiction Biology may shed some lights on this question.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.